Trial · NCT07885995
EFFECT OF COMBINED VIRTUAL REALITY-GUIDED BREATHING AND AEROBIC TRAINING ON VENTILATORY FUNCTION IN PATIENTS WITH COPD
NCT07885995, Not applicable, Not yet recruiting, Cairo University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. EFFECT OF COMBINED VIRTUAL REALITY-GUIDED BREATHING AND AEROBIC TRAINING ON VENTILATORY FUNCTION IN PATIENTS WITH COPD. Trials, record NCT07885995. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885995
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- EFFECT OF COMBINED VIRTUAL REALITY-GUIDED BREATHING AND AEROBIC TRAINING ON VENTILATORY FUNCTION IN PATIENTS WITH COPD
- NCT number
- NCT07885995
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Cairo University
- Conditions
- Chronic Obstructive Lung Disease
- Interventions
- VR-Based Pulmonary Rehabilitation Group, Conventional Pulmonary Rehabilitation Group
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Diaphragmatic Excursion | Baseline and 12 weeks after the start of the intervention. | Change in diaphragmatic excursion, measured in centimeters using diagnostic ultrasound during deep inspiration, from baseline to the end of the intervention period. |
| Primary | Forced Expiratory Volume in One Second (FEV₁) | Baseline and 12 weeks after the start of the intervention. | Change in forced expiratory volume in one second (FEV₁), measured using spirometry, from baseline to the end of the 12-week intervention period. |
| Secondary | Forced Vital Capacity (FVC) | Baseline and 12 weeks after the start of the intervention. | Change in forced vital capacity (FVC), measured using spirometry, from baseline to the end of the intervention period. |
| Secondary | FEV₁/FVC Ratio | Baseline and 12 weeks after the start of the intervention. | Change in the ratio of forced expiratory volume in one second to forced vital capacity (FEV₁/FVC), measured using spirometry, from baseline to the end of the intervention period. |
| Secondary | Six-Minute Walk Distance (6MWD) | Baseline and 12 weeks after the start of the intervention. | Change in six-minute walk distance, measured in meters using the standardized six-minute walk test, from baseline to the end of the intervention period. |
| Secondary | Peripheral Oxygen Saturation (SpO₂) | Baseline and 12 weeks after the start of the intervention. | Change in peripheral oxygen saturation (SpO₂), measured using pulse oximetry, from baseline to the end of the intervention period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07885995
GET https://conductscience.org/api/trials/v1/NCT07885995/registered